My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 220

    1.

    Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes.

    Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H.

    Diabetes. 2003 Oct;52(10):2586-93.PMID: 14514644 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.

    Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H.

    Diabetes. 2007 Feb;56(2):363-72. Erratum in: Diabetes. 2007 Mar;56(3):897. Takeya, Masahiro [corrected to Takeya, Motohiro]. PMID: 17259380 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.

    Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH.

    J Am Soc Nephrol. 2005 Jun;16(6):1711-22. Epub 2005 Apr 27.PMID: 15857924 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.

    Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, Usui H, Nagase R, Ogawa D, Okada S, Shikata Y, Wada J, Makino H.

    Diabetologia. 2005 Nov;48(11):2402-11. Epub 2005 Oct 18.PMID: 16231067 [PubMed - indexed for MEDLINE]Related articles

    5.

    Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy.

    Lu TC, Wang ZH, Feng X, Chuang PY, Fang W, Shen Y, Levy DE, Xiong H, Chen N, He JC.

    Kidney Int. 2009 Jul;76(1):63-71. Epub 2009 Apr 8.PMID: 19357722 [PubMed - indexed for MEDLINE]Related articles

    6.

    Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

    Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

    J Am Soc Nephrol. 2004 Aug;15(8):2125-38.PMID: 15284298 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury.

    Liu S, Shi L, Wang S.

    Am J Physiol Renal Physiol. 2007 Nov;293(5):F1727-35. Epub 2007 Sep 19.PMID: 17881461 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.

    Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H.

    Diabetes. 2007 Feb;56(2):346-54.PMID: 17259378 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats.

    Usui H, Shikata K, Matsuda M, Okada S, Ogawa D, Yamashita T, Hida K, Satoh M, Wada J, Makino H.

    Nephrol Dial Transplant. 2003 Feb;18(2):265-72. Erratum in: Nephrol Dial Transplant. 2003 Jul;18(7):1418. PMID: 12543879 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

    Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.

    Wu YG, Lin H, Qi XM, Wu GZ, Qian H, Zhao M, Shen JJ, Lin ST.

    Int Immunopharmacol. 2006 Mar;6(3):445-53. Epub 2005 Oct 12.PMID: 16428080 [PubMed - indexed for MEDLINE]Related articles

    12.

    Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

    Mizuno S, Nakamura T.

    Am J Physiol Renal Physiol. 2004 Jan;286(1):F134-43. Epub 2003 Sep 30.PMID: 14519594 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

    Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

    Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.

    Hamada Y, Fukagawa M.

    Kobe J Med Sci. 2007;53(1-2):53-61.PMID: 17582205 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats.

    Qian Y, Li S, Ye S, Chen Y, Zhai Z, Chen K, Yang G.

    J Endocrinol Invest. 2008 Dec;31(12):1069-74.PMID: 19246972 [PubMed - indexed for MEDLINE]Related articles

    16.

    The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.

    Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN.

    Ren Fail. 2001 May-Jul;23(3-4):471-81. Review.PMID: 11499562 [PubMed - indexed for MEDLINE]Related articles

    17.

    Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy.

    Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T.

    J Biol Chem. 2003 May 16;278(20):18229-34. Epub 2003 Mar 17.PMID: 12644472 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.

    Wu YG, Lin H, Qian H, Zhao M, Qi XM, Wu GZ, Lin ST.

    Inflamm Res. 2006 May;55(5):192-9.PMID: 16830106 [PubMed - indexed for MEDLINE]Related articles

    19.

    Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

    Ohga S, Shikata K, Yozai K, Okada S, Ogawa D, Usui H, Wada J, Shikata Y, Makino H.

    Am J Physiol Renal Physiol. 2007 Apr;292(4):F1141-50. Epub 2006 Dec 26.PMID: 17190910 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.

    Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.

    J Nephrol. 2003 Nov-Dec;16(6):841-9.PMID: 14736011 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity